Cargando…

Selecting and defining indicators for diabetes surveillance in Germany

Mainly because of the large number of people affected and associated significant health policy implications, the Robert Koch Institute (RKI) is developing a public health surveillance system using diabetes as an example. In a first step to ensure long-term and comparable data collection and establis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrys, Lars, Heidemann, Christin, Schmidt, Christian, Baumert, Jens, Teti, Andrea, Du, Yong, Paprott, Rebecca, Ziese, Thomas, Banzer, Winfried, Böhme, Michael, Borrmann, Brigitte, Busse, Reinhard, Freitag, Michael, Hagen, Bernd, Holl, Reinhard, Icks, Andrea, Kaltheuner, Matthias, Koch, Klaus, Kümmel, Stefanie, Kuhn, Joseph, Kuß, Oliver, Laux, Gunter, Schubert, Ingrid, Szecsenyi, Joachim, Uebel, Til, Zahn, Daniela, Scheidt-Nave, Christa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Robert Koch Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852787/
https://www.ncbi.nlm.nih.gov/pubmed/35586543
http://dx.doi.org/10.17886/RKI-GBE-2018-063
_version_ 1784653110181888000
author Gabrys, Lars
Heidemann, Christin
Schmidt, Christian
Baumert, Jens
Teti, Andrea
Du, Yong
Paprott, Rebecca
Ziese, Thomas
Banzer, Winfried
Böhme, Michael
Borrmann, Brigitte
Busse, Reinhard
Freitag, Michael
Hagen, Bernd
Holl, Reinhard
Icks, Andrea
Kaltheuner, Matthias
Koch, Klaus
Kümmel, Stefanie
Kuhn, Joseph
Kuß, Oliver
Laux, Gunter
Schubert, Ingrid
Szecsenyi, Joachim
Uebel, Til
Zahn, Daniela
Scheidt-Nave, Christa
author_facet Gabrys, Lars
Heidemann, Christin
Schmidt, Christian
Baumert, Jens
Teti, Andrea
Du, Yong
Paprott, Rebecca
Ziese, Thomas
Banzer, Winfried
Böhme, Michael
Borrmann, Brigitte
Busse, Reinhard
Freitag, Michael
Hagen, Bernd
Holl, Reinhard
Icks, Andrea
Kaltheuner, Matthias
Koch, Klaus
Kümmel, Stefanie
Kuhn, Joseph
Kuß, Oliver
Laux, Gunter
Schubert, Ingrid
Szecsenyi, Joachim
Uebel, Til
Zahn, Daniela
Scheidt-Nave, Christa
author_sort Gabrys, Lars
collection PubMed
description Mainly because of the large number of people affected and associated significant health policy implications, the Robert Koch Institute (RKI) is developing a public health surveillance system using diabetes as an example. In a first step to ensure long-term and comparable data collection and establish efficient surveillance structures, the RKI has defined a set of relevant indicators for diabetes surveillance. An extensive review of the available literature followed by a structured process of consensus provided the basis for a harmonised set of 30 core and 10 supplementary indicators. They correspond to the following four fields of activity: (1) reducing diabetes risk, (2) improving diabetes early detection and treatment, (3) reducing diabetes complications, (4) reducing the disease burden and overall costs of the disease. In future, in addition to the primary data provided by RKI health monitoring diabetes surveillance needs to also consider the results from secondary data sources. Currently, barriers to accessing this data remain, which will have to be overcome, and gaps in the data closed. The RKI intentends to continuously update this set of indicators and at some point apply it also to further chronic diseases with high public health relevance.
format Online
Article
Text
id pubmed-8852787
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Robert Koch Institute
record_format MEDLINE/PubMed
spelling pubmed-88527872022-05-17 Selecting and defining indicators for diabetes surveillance in Germany Gabrys, Lars Heidemann, Christin Schmidt, Christian Baumert, Jens Teti, Andrea Du, Yong Paprott, Rebecca Ziese, Thomas Banzer, Winfried Böhme, Michael Borrmann, Brigitte Busse, Reinhard Freitag, Michael Hagen, Bernd Holl, Reinhard Icks, Andrea Kaltheuner, Matthias Koch, Klaus Kümmel, Stefanie Kuhn, Joseph Kuß, Oliver Laux, Gunter Schubert, Ingrid Szecsenyi, Joachim Uebel, Til Zahn, Daniela Scheidt-Nave, Christa J Health Monit Concepts & Methods Mainly because of the large number of people affected and associated significant health policy implications, the Robert Koch Institute (RKI) is developing a public health surveillance system using diabetes as an example. In a first step to ensure long-term and comparable data collection and establish efficient surveillance structures, the RKI has defined a set of relevant indicators for diabetes surveillance. An extensive review of the available literature followed by a structured process of consensus provided the basis for a harmonised set of 30 core and 10 supplementary indicators. They correspond to the following four fields of activity: (1) reducing diabetes risk, (2) improving diabetes early detection and treatment, (3) reducing diabetes complications, (4) reducing the disease burden and overall costs of the disease. In future, in addition to the primary data provided by RKI health monitoring diabetes surveillance needs to also consider the results from secondary data sources. Currently, barriers to accessing this data remain, which will have to be overcome, and gaps in the data closed. The RKI intentends to continuously update this set of indicators and at some point apply it also to further chronic diseases with high public health relevance. Robert Koch Institute 2018-06-06 /pmc/articles/PMC8852787/ /pubmed/35586543 http://dx.doi.org/10.17886/RKI-GBE-2018-063 Text en © Robert Koch Institute. All rights reserved unless explicitly granted. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Concepts & Methods
Gabrys, Lars
Heidemann, Christin
Schmidt, Christian
Baumert, Jens
Teti, Andrea
Du, Yong
Paprott, Rebecca
Ziese, Thomas
Banzer, Winfried
Böhme, Michael
Borrmann, Brigitte
Busse, Reinhard
Freitag, Michael
Hagen, Bernd
Holl, Reinhard
Icks, Andrea
Kaltheuner, Matthias
Koch, Klaus
Kümmel, Stefanie
Kuhn, Joseph
Kuß, Oliver
Laux, Gunter
Schubert, Ingrid
Szecsenyi, Joachim
Uebel, Til
Zahn, Daniela
Scheidt-Nave, Christa
Selecting and defining indicators for diabetes surveillance in Germany
title Selecting and defining indicators for diabetes surveillance in Germany
title_full Selecting and defining indicators for diabetes surveillance in Germany
title_fullStr Selecting and defining indicators for diabetes surveillance in Germany
title_full_unstemmed Selecting and defining indicators for diabetes surveillance in Germany
title_short Selecting and defining indicators for diabetes surveillance in Germany
title_sort selecting and defining indicators for diabetes surveillance in germany
topic Concepts & Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852787/
https://www.ncbi.nlm.nih.gov/pubmed/35586543
http://dx.doi.org/10.17886/RKI-GBE-2018-063
work_keys_str_mv AT gabryslars selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT heidemannchristin selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT schmidtchristian selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT baumertjens selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT tetiandrea selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT duyong selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT paprottrebecca selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT ziesethomas selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT banzerwinfried selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT bohmemichael selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT borrmannbrigitte selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT bussereinhard selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT freitagmichael selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT hagenbernd selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT hollreinhard selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT icksandrea selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT kaltheunermatthias selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT kochklaus selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT kummelstefanie selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT kuhnjoseph selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT kußoliver selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT lauxgunter selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT schubertingrid selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT szecsenyijoachim selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT uebeltil selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT zahndaniela selectinganddefiningindicatorsfordiabetessurveillanceingermany
AT scheidtnavechrista selectinganddefiningindicatorsfordiabetessurveillanceingermany